EUVIMEDEUVIMED entdecken
Crossref

Cuproptosis‐related classification and personalized treatment in lower‐grade gliomas to prompt precise oncology

Nanxi Shen, Shu Chen, Dong Liu, Xiangde Min, Qinghai Tan

The Journal of Gene Medicine · 2023

DOI: 10.1002/jgm.3486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2023. Verfasst von Nanxi Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Glioma, Precision Medicine, Apoptosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cuproptosis is implicated in regulating tricarboxylic acid cycle and associated with tumor therapeutic sensitivity, patient outcomes and tumorigenesis. However, the classification and prognostic effect of cuproptosis‐associated genes (CAGs), the relationship between cuproptosis and tumor microenvironment (TME) and the treatment of lower‐grade glioma (LrGG) remain enigmatic.

Methods

The genetic and transcriptional alterations, prognostic value and classification related to cuproptosis were systematically analyzed. Subtypes of cuproptosis and cuproptosis score (Cuscore) were constructed and further confirmed by two external cohorts. The relationships between cuproptosis and TME, prognosis, and treatment response were also evaluated.

Results

Four clusters were identified based on cuproptosis‐associated genes. The associations between cuproptosis‐associated clusters and clinical features, prognosis, immune cell infiltration, and chemotherapy sensitivity were observed. The Cuscore is an independent prognostic indicator in LrGG patients. The nomogram is constructed according to Cuscore and clinical characteristics, and has good predictive ability and calibration. Patients with high Cuscore had a worse prognosis and advanced performance. A higher Cuscore also indicated a higher stromal score, abundant immune infiltration, and increased tumor mutation burden. A high Cuscore was remarkably related to immune checkpoint inhibitors, immunotherapy response and immune phenotype.

Conclusions

This study demonstrates the clinical effect of CAGs, and suggests that cuproptosis could be a potential therapeutic target in LrGG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaPrecision MedicineApoptosisHumansCarcinogenesisCell Transformation, NeoplasticImmunotherapyTumor MicroenvironmentCopper

Stichwörter der Autor:innen

chemotherapycuproptosislower-grade gliomaprognosistumor microenvironment

Substanzen

Copper

Autor:innen und Institutionen

  • Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • United Imaging Intelligence, Shanghai, China.
  • Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Shen, N., Chen, S., Liu, D., Min, X., & Tan, Q. (2023). Cuproptosis‐related classification and personalized treatment in lower‐grade gliomas to prompt precise oncology. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3486

Vancouver

Shen N, Chen S, Liu D, Min X, Tan Q. Cuproptosis‐related classification and personalized treatment in lower‐grade gliomas to prompt precise oncology. The Journal of Gene Medicine. 2023. doi:10.1002/jgm.3486

BibTeX
@article{Shen2023,
  author = {Shen, Nanxi and Chen, Shu and Liu, Dong and Min, Xiangde and Tan, Qinghai},
  title = {Cuproptosis‐related classification and personalized treatment in lower‐grade gliomas to prompt precise oncology},
  journal = {The Journal of Gene Medicine},
  year = {2023},
  doi = {10.1002/jgm.3486}
}
Kostenlos starten →